Poster
Tyler Peat
NIH/NCI, MD
Title: High-throughput screen identifies novel combinations targeting drug-resistant multiple myeloma
Linda Senbanjo
University of Maryland, Department of Oncology and Diagnostic Sciences, Dental School, Baltimore, MD
Title: CD44 Intracellular domain interaction with Runx2 regulates prostate cancer metastasis
Bhuban Ruidas
Indian Institute of Engineering Science and Technology Shibpur, India
Title: Traditional Herbal Drug Repairing Metabolic Alteration In Breast Cancer Cells To Induce Cell Death In-Vitro And In-Vivo
Hossam Tashkandi
University of South Carolina, SC
Title: Panaxynol as a Potential Ulcerative Colitis Therapeutic
Angela Takacs
Semmelweis University, Hungary
Title: In-vitro Tested Derivatives of ONC201 Can have an Antitumor Effect in Pancreatic and in Colorectal Cancer Cell Lines
Sean Fleming
University of Maryland, Baltimore
Title: Disparities in Healthcare Utilization among Patients with Four Common Cancers, Maryland and West Virginia, 2005 and 2014
Jaqueline de Lima Munhoz
University of Campinas- UNICAMP, Brazil
Title: Immunomodulation as a Target Using Molecules Extracted from Brazilian Spider Venom: A News Perspectives for the Treatment of Cancer
Changyu Zhu
Sichuan Provincial People's Hospital, China
Title: Mettl3 Promoted Autophagy in Epithelial Ovarian Cancer
Xia He
Sichuan Provincial People's hospital, China
Title: The Relativity of Genetic Polymorphisms to Plasma Methotrexate Levels and Toxicities of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia
Andres Felipe Aristizabal Pachon
Pontifical Javeriana University, Colombia
Title: miRNAs-C19MC Regulate the Proliferation, Invasion and Migration in SKBR3 Cell Lines
Marufa Rumman
Wayne State University
Title: ONC201 Induces the Unfolded Protein Response (UPR) in High and Low Grade Ovarian Carcinoma Cell Lines and Leads to Cell Death Regardless of Platinum Sensitivity
David Vetvicka
1st Faculty of Medicine, Charles University, Czech Republic
Title: Novel Stimuli-Responsive Polymeric Drug Delivery System for Doxorubicine
Fahad Mubariz
University of Maryland, School of Medicine, MD
Title:Inverse relation between FoxM1 and RASSF1A as a therapeutic target of Colon cancer
Neha Sharda
University of Maryland, School of Medicine, MD
Title: Inverse relation between FoxM1 and RASSF1A as a therapeutic target of Colon cancer